<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Recently, serum beta2-microglobulin, an endogenous marker for renal function, has been shown to be an independent predictor of mortality in older adults </plain></SENT>
<SENT sid="1" pm="."><plain>However, the prognostic role of beta2-microglobulin in <z:hpo ids='HP_0001635'>heart failure</z:hpo> has not been elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We prospectively evaluated serum beta2-microglobulin and <z:chebi fb="0" ids="16737">creatinine</z:chebi> concentrations, <z:chebi fb="0" ids="16737">creatinine</z:chebi>-based renal parameters (estimated glomerular filtration rate and <z:chebi fb="0" ids="16737">creatinine</z:chebi> clearance), and echocardiographic data in 131 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo> and <z:chebi fb="0" ids="16737">creatinine</z:chebi> concentrations &lt; or =3.0mg/dL admitted to our hospitals </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: During 2.3+/-1.3 years, 42 patients died of cardiovascular causes and 12 died of noncardiac causes </plain></SENT>
<SENT sid="4" pm="."><plain>Cardiovascular events were observed in 63 patients: 53 were readmitted due to worsening <z:hpo ids='HP_0001635'>heart failure</z:hpo>, 5 readmitted for <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e>, and 5 died from <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>According to multivariate stepwise Cox proportional hazard analysis, higher baseline serum beta2-microglobulin concentrations (X(2)=16, p&lt;0.0001), previous <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> (X(2)=11, p&lt;0.001), presence of <z:hpo ids='HP_0006510'>chronic obstructive pulmonary disease</z:hpo> (X(2)=8, p&lt;0.01), and lower diastolic blood pressure (X(2)=6, p&lt;0.05) were independent predictors of increased cardiovascular events </plain></SENT>
<SENT sid="6" pm="."><plain>Also, higher baseline serum beta2-microglobulin (X(2)=20, p&lt;0.0001), lower systolic blood pressure (X(2)=11, p&lt;0.001), higher relative left ventricular wall thickness (X(2)=6, p&lt;0.05), and lower body mass index (X(2)=5, p&lt;0.05) were independent predictors of increased cardiac mortality </plain></SENT>
<SENT sid="7" pm="."><plain>The adjusted hazard ratio for cardiovascular events increased with baseline serum beta2-microglobulin above 2.1 mg/L: 2.9 with beta2-microglobulin of 2.2-2.6 mg/L (95%CI 1.2-6.9, p&lt;0.05), 2.9 with beta2-microglobulin of 2.7-3.9 mg/L (95%CI 1.2-7.2, p&lt;0.05), and 4.7 with beta2-microglobulin of &gt; or =4.0 mg/L (95%CI 2.0-11, p&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Higher baseline serum beta2-microglobulin concentration could be a promising risk marker in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo> patients with <z:chebi fb="0" ids="16737">creatinine</z:chebi> &lt; or =3.0 mg/dL </plain></SENT>
</text></document>